Marktanalyse - Healthcare Providers in South Korea

Introduction

Healthcare Providers in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the South Korea healthcare providers market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*The healthcare providers sector is valued as total expenditure on healthcare in each country. This includes final consumption spending on healthcare goods and services.

*The South Korean healthcare providers sector is expected to generate total revenue of $75.4 billion in 2011, representing a compound annual growth rate (CAGR) of 9.1% between 2007 and 2011.

*The outpatient care segment is expected to be the sectors most lucrative in 2011, with total revenue of $26.4 billion, equivalent to 35% of the sector's overall value.

*The performance of the sector is forecast to decelerate slightly, with an anticipated CAGR of 8.9% for the five-year period 2011 - 2016, which is expected to drive the sector to a value of $115.4 billion by the end of 2016.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the healthcare providers market in South Korea

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the healthcare providers market in South Korea

Leading company profiles reveal details of key healthcare providers market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the South Korea healthcare providers market with five year forecasts

Macroeconomic indicators provide insight into general trends within the South Korea economy

Key Questions Answered

What was the size of the South Korea healthcare providers market by value in 2011?

What will be the size of the South Korea healthcare providers market in 2016?

What factors are affecting the strength of competition in the South Korea healthcare providers market?

How has the market performed over the last five years?

What are the main segments that make up South Korea's healthcare providers market?

TABLE OF CONTENTS

EXECUTIVE SUMMARY 2

MARKET OVERVIEW 6

Market definition 6

Market analysis 6

MARKET DATA 7

Market value 7

MARKET SEGMENTATION 8

Category segmentation 8

Geography segmentation 9

MARKET OUTLOOK 10

Market value forecast 10

FIVE FORCES ANALYSIS 11

Summary 11

Buyer power 12

Supplier power 14

New entrants 16

Threat of substitutes 18

Degree of rivalry 19

LEADING COMPANIES 20

Asan Medical Center 20

Samsung Medical Centre 21

Wooridul Spine Hospital 22

MACROECONOMIC INDICATORS 23

Country Data 23

APPENDIX 25

Methodology 25

Industry associations 26

Related Datamonitor research 26



LIST OF TABLES

Table 1: South Korea healthcare providers sector value: $ billion, 2007—11 7

Table 2: South Korea healthcare providers sector category segmentation : $million, by value, 2011 8

Table 3: South Korea healthcare providers sector geography segmentation : $million, by value, 2011 9

Table 4: South Korea healthcare providers sector value forecast: $ billion, 2011—16 10

Table 5: Asan Medical Center: key facts 20

Table 6: Samsung Medical Centre: key facts 21

Table 7: Wooridul Spine Hospital: key facts 22

Table 8: South Korea size of population (million), 2007—11 23

Table 9: South Korea GDP (constant 2000 prices, $ billion), 2007—11 23

Table 10: South Korea GDP (current prices, $ billion), 2007—11 23

Table 11: South Korea inflation, 2007—11 23

Table 12: South Korea consumer price index (absolute), 2007—11 24

Table 13: South Korea exchange rate, 2007—11 24



LIST OF FIGURES

Figure 1: South Korea healthcare providers sector value: $ billion, 2007—11 7

Figure 2: South Korea healthcare providers sector category segmentation : % share, by value, 2011 8

Figure 3: South Korea healthcare providers sector geography segmentation : % share, by value, 2011 9

Figure 4: South Korea healthcare providers sector value forecast: $ billion, 2011—16 10

Figure 5: Forces driving competition in the healthcare providers sector in South Korea, 2011 11

Figure 6: Drivers of buyer power in the healthcare providers sector in South Korea, 2011 12

Figure 7: Drivers of supplier power in the healthcare providers sector in South Korea, 2011 14

Figure 8: Factors influencing the likelihood of new entrants in the healthcare providers sector in South Korea, 2011 16

Figure 9: Factors influencing the threat of substitutes in the healthcare providers sector in South Korea, 2011 18

Figure 10: Drivers of degree of rivalry in the healthcare providers sector in South Korea, 2011 19

• CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France
• CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy
• Consumer Health in Chile
• Consumer Health in China
• Consumer Health in Poland
• Healthcare, Regulatory and Reimbursement Landscape - Argentina
• Healthcare, Regulatory and Reimbursement Landscape - Belgium
• Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players
• New Product Development Trends in Consumer Health 2013
• Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals
• Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013
• Consumer Health in Uruguay
• Healthcare, Regulatory and Reimbursement Landscape - Austria
• Healthcare, Regulatory and Reimbursement Landscape - Finland
• Healthcare, Regulatory and Reimbursement Landscape - Norway
• Healthcare, Regulatory and Reimbursement Landscape - Portugal
• Healthcare, Regulatory and Reimbursement Landscape - Sweden
• Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals
• Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012
• China Pharmaceutical Market Outlook - Government Incentives, Healthcare Reform and a Rapidly Ageing Population Provide Strong Stimulus for Growth